NGM Biopharmaceuticals Inc (DELISTED) (NGM:DL)
1.55
USD |
NASDAQ |
Apr 04, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 128.53M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -60.81% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 28.76 |
| Price to Book Value | 0.8647 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 98.12% |
Profile
| N/A |
| URL | N/A |
| Investor Relations URL | https://ir.ngmbio.com/ |
| HQ State/Province | N/A |
| Sector | |
| Industry | |
| Next Earnings Release | May. 03, 2024 (est.) |
| Last Earnings Release | Mar. 11, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| N/A |
| URL | N/A |
| Investor Relations URL | https://ir.ngmbio.com/ |
| HQ State/Province | N/A |
| Sector | |
| Industry | |
| Next Earnings Release | May. 03, 2024 (est.) |
| Last Earnings Release | Mar. 11, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |